Skip to content
10-K

Annual Report

ALDEYRA THERAPEUTICS, INC. ALDX

0001193125-26-083012

← back to feed
Filed
Feb 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 27, 2026 60.18M sh
Shares Diluted FY 2025 · Dec 31, 2025 60.06M sh
Shares Diluted FY 2025 · Dec 31, 2024 59.48M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$33.35M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$43.21M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $15M
Short Term Debt FY 2025 · Dec 31, 2025 $15.25M
Short Term Debt FY 2025 · Dec 31, 2024 $31.37K
Cash And Equivalents FY 2025 · Dec 31, 2025 $70.04M
Cash And Equivalents FY 2025 · Dec 31, 2024 $54.53M
Stockholders Equity FY 2025 · Dec 31, 2025 $44.25M
Stockholders Equity FY 2025 · Dec 31, 2024 $71M
Stockholders Equity FY 2025 · Dec 31, 2023 $119.8M
Current Liabilities FY 2025 · Dec 31, 2025 $27.81M
Current Liabilities FY 2025 · Dec 31, 2024 $18.6M
Total Liabilities FY 2025 · Dec 31, 2025 $27.81M
Total Liabilities FY 2025 · Dec 31, 2024 $33.6M
Current Assets FY 2025 · Dec 31, 2025 $71.78M
Current Assets FY 2025 · Dec 31, 2024 $104.07M
Total Assets FY 2025 · Dec 31, 2025 $72.06M
Total Assets FY 2025 · Dec 31, 2024 $104.61M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.56
Eps Diluted FY 2025 · Dec 31, 2024 −$0.94
Eps Basic FY 2025 · Dec 31, 2025 −$0.56
Eps Basic FY 2025 · Dec 31, 2024 −$0.94
Sga Expense FY 2025 · Dec 31, 2025 $9.6M
Sga Expense FY 2025 · Dec 31, 2024 $11.89M
Rd Expense FY 2025 · Dec 31, 2025 $25.66M
Rd Expense FY 2025 · Dec 31, 2024 $48.22M
Net Income FY 2025 · Dec 31, 2025 −$33.85M
Net Income FY 2025 · Dec 31, 2024 −$55.85M
Operating Income FY 2025 · Dec 31, 2025 −$35.27M
Operating Income FY 2025 · Dec 31, 2024 −$60.12M